glp-1 receptor agonist kidney outcomes semaglutide flow trial 2024 results Media Centre Semaglutide could be 'practice changing'

**Tirzepatide** acts on both GLP-1 and GIP receptors, offering dual hormone action

Your medical team will track your progress, monitor for side effects, and make adjustments to your dosage or treatment length as needed

This may be attributed to patients gradually adapting to the medication during the treatment process or other factors

They trust us because we provide answers rather than uncertainty

If you find you prefer certain injection sites over others (or if you dont have someone who can give you the injection in your arm), you can use the same general areajust be sure to inject in a spot at least 1 inch away from where you injected Ozempic last time

2019 Jan 6;8(1):15